2025 US Biotech Investor List – Therapeutics Focus + (Their Direct Professional Emails)

Discover the benefits of using our list:

Reach your target 

With direct email addresses of 1583 U.S. Therapeutics Investors’ decision-makers (Partners, Principals, Associates) actively funding Therapeutics.

Match Perfectly with Your Needs

Pre-filtered by investment stage (Seed to Series E) and ticket size (250K–10M+).

Access Hidden Opportunities

Discover hidden investors specialized in your therapeutics niche (oncology, rare diseases, drug discovery).

Launch Targeted Outreach Instantly

CSV/Excel files formatted for immediate use contact all 1,583 decision-makers in few clicks.

Free your team to focus on what matters: your innovations.

Claim Your List Now !

Close Your Next Round Faster !

# What you will receive

an Excel file for manual browsing and a CSV file packed with : 

✅ a Direct Access to your future partner

1583 First-name contacts (Partners, Principals) at 266 U.S. Therapeutics VC firms – no assistants or generic addresses.

✅ a Match Perfectly with Your Needs

Pre-screened by active engagement in Seed to Series E rounds.

✅ a Full Portfolio Transparency

Access investor website URLs and active portfolio companies

✅ a Global Footprint Transparency

HQ locations + all operational countries.

✅ an Alternative Outreach Paths

Generic emails (info@, contact@) + direct links to contact forms

Want an in-depth look at every data point? Click here to discover all the details.

Data freshness: Updated April 4 2025

Need specifics? Contact our data team here.

Data sourced from proprietary research